Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
BUD
NYSE·Consumer Defensive·Beverages - Alcoholic·Mkt cap $155.2B
$81.33
▲ +1.35%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$56.97 - $85.56
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Up 15.7% over the trailing year
Total returns
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
Bear Case
2 risks
Growth
Revenue decline expected
Premiumization trend driving higher-margin product sales in developed markets
Value
Premium valuation to Alcoholic Beverages peers
Momentum
Strong
+12.6% over 3m
Quality
Strong
Excellent business quality
Dividend
Modest
1.19% yield
Smart-money signal
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Jul 30, 2026
MAY 5, 2026
Reported EPS of $1.52 vs $0.90 consensus (+68.9% surprise). Revenue of $29.5B vs $14.7B expected (+100.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+68.9%
Next: Jul 30, 2026
Revenue trend · last 8Q
—
—
+5%
+1%
+2%
-1%
+0%
+2%
Q2 22
Q4 22
Q2 23
Q4 23
Q2 24
Q4 24
Q2 25
Q4 25
$28.0B
$29.8B
$29.3B
$30.0B
$29.9B
$29.9B
$30.0B
$30.6B
Margins · last 8Q
Gross
55.9%
Operating
25.5%
Profit
9.8%
Wall Street consensus
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
$82.00
▲ +0.8% vs $81.33
Latest: Barclays · Jun 30, 2026
1 analyst covering